Skip to main navigation Skip to search Skip to main content

Keloidal atypical fibroxanthoma of the scalp

  • Kathryn McClelland
  • , Aidan Brady
  • , Paula Reid
  • , Joseph Houghton

Research output: Contribution to journalArticlepeer-review

75 Downloads (Pure)

Abstract

Atypical fibroxanthoma (AFX) is a rare low-grade sarcoma that occurs mainly in the elderly and may recur locally. There are multiple variants including keloidal AFX (KAF). KAF is characterised by a proliferation of atypical spindled and epithelioid cells admixed with bizarre pleomorphic cells. These cells intersect among broad bands of keloidal collagen. AFX is a diagnosis of exclusion so a broad panel of immunohistochemical staining should be applied to rule out other differentials (squamous cell carcinoma (SCC), melanoma, leiomyosarcoma, etc). There is added difficulty with the diagnosis of KAF as it may mimic multiple keloidal lesions, including exuberant scarring, as in this case. p53 immunohistochemistry staining can be useful in highlighting the presence of tumour cells. Additionally, next generation sequencing can detect genetic mutations identified in clonal proliferations consistent with tumour formation. KAF is easily overlooked and it should be included in the differential diagnosis for keloidal lesions showing even mild atypia.
Original languageEnglish
Article numbere258025
JournalBMJ Case Reports
Volume16
Issue number11
Publication statusPublished - 16 Nov 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Keloidal atypical fibroxanthoma of the scalp'. Together they form a unique fingerprint.

Cite this